The efficacy of sorafenib against hepatocellular carcinoma is enhanced by 5‐aza‐mediated inhibition of<scp>ID1</scp>promoter methylation
Jing Meng(Second Hospital of Shandong University), Leilei Niu(Chinese University of Hong Kong)
Cited by 2
Related Papers
ID1-induced p16/IL6 axis activation contributes to the resistant of hepatocellular carcinoma cells to sorafenib
|Cell Death and Disease|2018|26